Skip to content
value.today

Medicine Man Technologies, Inc.

Total raised
$153 M
4 rounds on record
Latest round
$95 M
Dec 2021
First round on record
Aug 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 6 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Medicine Man Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$16 MIssued in a merger or acquisition$10 to $50 million

Medicine Man Technologies, Inc.: Private sale, Apr 2023

Investors in this round

1 investor had bought by the notice of May 5, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Justin Dye · Executive Officer, Director
  • Nirup Krishnamurthy · Executive Officer, Director
  • Bradley Stewart · Director
  • Christine Jones · Director
  • Forrest Hoffmaster · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Marc Rubin · Director
  • Paul Montalbano · Director
  • Pratap Mukharji · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christine Jones, Chief Legal Officer. Newest notice filed May 5, 2023. Read the notice at the SEC.

equitySEC
Apr 2023$6 MIssued in a merger or acquisition$2 to $10 million

Medicine Man Technologies, Inc.: Private sale, Apr 2023

Investors in this round

1 investor had bought by the notice of Apr 27, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$300,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Christine Jones · Executive Officer
  • Forrest Hoffmaster · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nirup Krishnamurthy · Executive Officer, Director
  • Brad Stewart · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Marc Rubin · Director
  • Paul Montalbano · Director
  • Pratap Mukharji · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cannabis Capital Advisors · Denver, ColoradoSold in CO

Signed by Christine Jones, Chief Legal Officer. Newest notice filed Apr 27, 2023. Read the notice at the SEC.

equitySEC
Jan 2023$4 MIssued in a merger or acquisition$2 to $10 million

Medicine Man Technologies, Inc.: Private sale, Jan 2023

Investors in this round

3 investors had bought by the notice of Feb 9, 2023: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$150,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Daniel Pabon · Executive Officer
  • Forrest Hoffmaster · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nirup Krishnamurthy · Executive Officer, Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Marc Rubin · Director
  • Paul Montalbano · Director
  • Pratap Mukharji · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aaron Shaw · Louisville, ColoradoSold in CO

Signed by Daniel Pabon, General Counsel. Newest notice filed Feb 9, 2023. Read the notice at the SEC.

equitySEC
Mar 2022$2 MIssued in a merger or acquisitionUnder $2 million

Medicine Man Technologies, Inc.: Private sale, Mar 2022

Investors in this round

2 investors had bought by the notice of Mar 28, 2022: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Daniel Pabon · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nancy Huber · Executive Officer
  • Nirup Krishnamurthy · Executive Officer, Director
  • Brian Ruden · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Justin Dye, Authorized Representative. Newest notice filed Mar 28, 2022. Read the notice at the SEC.

equitySEC
Feb 2022$12 MIssued in a merger or acquisition$10 to $50 million

Medicine Man Technologies, Inc.: Private sale, Feb 2022

Investors in this round

6 investors had bought by the notice of Feb 25, 2022: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Daniel Pabon · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nancy Huber · Executive Officer
  • Nirup Krishnamurthy · Executive Officer, Director
  • Brian Ruden · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Paul Montalbano · Director
  • Pratap Mukharji · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Justin Dye, Authorized Representative. Newest notice filed Feb 25, 2022. Read the notice at the SEC.

equitySEC
Dec 2021$95 MNo. 4$50 to $250 million

Medicine Man Technologies, Inc.: Raise no. 4, Dec 2021

Investors in this round

31 investors had bought by the notice of Dec 20, 2021: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$95 M of $95 M offered
Smallest investment taken
$100,000
What was sold
equity, debt, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,163,750
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Daniel Pabon · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nancy Huber · Executive Officer
  • Nirup Krishnamurthy · Executive Officer, Director
  • Brian Ruden · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Jonathan Berger · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • The Benchmark Company, LLC (CRD 22982) · New York, New YorkSold in CA, CO, CT, FL, GA, IL, MA, MN, NJ, NV, NY, TX

Signed by Justin Dye, Authorized Representative. Newest notice filed Dec 20, 2021. Read the notice at the SEC.

equity, debtSEC
Jul 2021$5 MIssued in a merger or acquisition$2 to $10 million

Medicine Man Technologies, Inc.: Private sale, Jul 2021

Investors in this round

2 investors had bought by the notice of Aug 5, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Dan Pabon · Executive Officer
  • Justin Dye · Executive Officer, Director
  • Nancy Huber · Executive Officer
  • Nirup Krishnamurthy · Executive Officer
  • Brian Ruden · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Pratap Mukharji · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuer withheld approximately $0.1 million of amount sold as collateral for potential indemnification from forfeiture.”

Signed by Daniel R. Pabon, Authorized Representative. Newest notice filed Aug 5, 2021. Read the notice at the SEC.

equitySEC
Dec 2020$54 MNo. 3$50 to $250 million

Medicine Man Technologies, Inc.: Raise no. 3, Dec 2020

Investors in this round

13 investors had bought by the notice of Mar 17, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$54 M of $65 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$677,200
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Dan Pabon · Executive Officer
  • Justin Dye · Executive Officer
  • Nancy Huber · Executive Officer
  • Brian Ruden · Director
  • Jeffrey Cozad · Director
  • Jeffrey Garwood · Director
  • Nirup Krishnamurthy · Director
  • Pratap Mukharji · Director
  • Salim Wahdan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Globalist Capital, LLC (CRD 152786) · Santa Monica, CaliforniaSold in all US states
  • Independent Brokerage Solutions (CRD 153563) · New York, New YorkSold in all US states
  • The Benchmark Company LLC (CRD 22982) · New York, New YorkSold in all US states

Signed by Nancy Huber, Chief Financial Officer. Newest notice filed Mar 17, 2021 (1 amendment). Read the notice at the SEC.

equity, debt, optionsSEC
Jun 2019$3 MNo. 2$2 to $10 million

Medicine Man Technologies, Inc.: Raise no. 2, Jun 2019

Investors in this round

1 investor had bought by the notice of Jun 14, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $14 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Andrew Williams · Executive Officer, Director
  • Joseph P. Puglise · Executive Officer
  • Joshua P. Haupt · Executive Officer
  • Paul Dickman · Executive Officer, Director
  • Justin P. Dye · Director
  • Leonardo P. Riera · Director
  • Robert P. DeGabrielle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Williams, Ceo. Newest notice filed Jun 14, 2019. Read the notice at the SEC.

equity, optionsSEC
Aug 2017$1 MNo. 1Under $2 million

Medicine Man Technologies, Inc.: Raise no. 1, Aug 2017

Investors in this round

1 investor had bought by the notice of Sep 12, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Medicine Man Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brett Roper · Executive Officer, Director
  • Jonathan Sandberg · Executive Officer
  • Joshua Haupt · Executive Officer
  • Andrew C. Williams · Director
  • Charles C. Haupt · Director
  • James C. Toreson · Director
  • Paul Dickman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brett Roper, Ceo. Newest notice filed Sep 12, 2017. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medicine Man Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2023

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in Medicine Man Technologies, Inc.
InvestorKindAmountRoundRoleSource
CRW Capital Cann Holdings, LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2021)SEC Form 3
CRW Capital Holdings II, LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2022)SEC Form 3
CRW Capital, LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Naser Ahmad JoudehPersonnot statednot statedHeld Series A preferred stock (Form 3, 2021)SEC Form 3
Salim Husan WahdanPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2021)SEC Form 3

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medicine Man Technologies, Inc.
NameRoleNamed in
Justin DyeExecutive officerMay 2023
Nirup KrishnamurthyExecutive officerMay 2023
Christine JonesExecutive officerApr 2023
Forrest HoffmasterExecutive officerApr 2023
Daniel PabonExecutive officerFeb 2023
Nancy HuberExecutive officerMar 2022
Dan PabonExecutive officerAug 2021
Andrew WilliamsExecutive officerJun 2019
Joseph P. PugliseExecutive officerJun 2019
Joshua P. HauptExecutive officerJun 2019
Paul DickmanExecutive officerJun 2019
Brett RoperExecutive officerSep 2017
Jonathan SandbergExecutive officerSep 2017
Joshua HauptExecutive officerSep 2017
Bradley StewartDirectorMay 2023
Christine JonesDirectorMay 2023
Forrest HoffmasterDirectorMay 2023
Jeffrey CozadDirectorMay 2023
Jeffrey GarwoodDirectorMay 2023
Jonathan BergerDirectorMay 2023
Justin DyeDirectorMay 2023
Marc RubinDirectorMay 2023
Nirup KrishnamurthyDirectorMay 2023
Paul MontalbanoDirectorMay 2023
Pratap MukharjiDirectorMay 2023
Brad StewartDirectorApr 2023
Salim WahdanDirectorFeb 2023
Brian RudenDirectorMar 2022
Leonardo RieraDirectorDec 2020
Andrew WilliamsDirectorJun 2019
Justin P. DyeDirectorJun 2019
Leonardo P. RieraDirectorJun 2019
Paul DickmanDirectorJun 2019
Robert P. DeGabrielleDirectorJun 2019
Andrew C. WilliamsDirectorSep 2017
Brett RoperDirectorSep 2017
Charles C. HauptDirectorSep 2017
James C. ToresonDirectorSep 2017